A retrospective study of cabazitaxel and/or enzalutamide in metastatic castration-resistant prostate cancer patients after treatment with both abiraterone and docetaxel.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Cabazitaxel (Primary) ; Enzalutamide (Primary) ; Abiraterone; Docetaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 Aug 2016 New trial record